US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dianthus Therapeutics Inc.

32.92

-0.3500-1.05%

Post-market: 32.920.00000.00%16:26 EDT

Volume:779.37K

Turnover:25.75M

Market Cap:1.31B

PE:-10.13

High:33.80

Open:33.69

Low:32.35

Close:33.27

52wk High:40.16

52wk Low:13.37

Shares:39.80M

Float Shares:21.08M

Volume Ratio:1.63

T/O Rate:3.70%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2490

EPS(LYR):-2.5506

ROE:-34.71%

ROA:-23.37%

PB:4.32

PE(LYR):-12.91

Loading ...

Overview Company News Filings

Dianthus Therapeutics announces exclusive licensing agreement with Nanjing Leads Biolabs for DNTH212

Dianthus Therapeutics Inc - Reaffirms Cash Runway Into 2028

THOMSON REUTERS

Dianthus Therapeutics Inc - Under the Term, Co to Pay Leads Biolabs up to $38 Mln

THOMSON REUTERS

Dianthus Therapeutics Announces Exclusive License Agreement With Leads Biolabs for Dnth212, a First and Potentially Best-in-Class, Phase 1 Ready Bifunctional Bdca2 & Baff/April Inhibitor for Severe Autoimmune Diseases

THOMSON REUTERS

Dianthus Therapeutics Inc - Estimated Pro Forma Cash Balance at $525 Mln Following the in-Licensing of Dnth212

THOMSON REUTERS

Dianthus initiated with a Buy at Truist

Dianthus Therapeutics Announces Positive Phase 2 Results for Claseprubart in Generalized Myasthenia Gravis; Data to Be Presented at 2025 AANEM Annual Meeting

Dianthus, Opendoor, and More Stocks See Action From Activist Investors -- Barrons.com

William Blair Keeps Their Buy Rating on Dianthus Therapeutics (DNTH)

Dianthus initiated with a Buy at Clear Street

Dianthus Therapeutics Is Maintained at Buy by Stifel

Dianthus price target raised to $44 from $42 at Wedbush

Wedbush Raises Price Target on Dianthus Therapeutics to $44 From $42, Keeps Outperform Rating

MT Newswires Live

CFO Ryan Savitz Reports Disposal of Common Shares in Dianthus Therapeutics Inc

Dianthus Therapeutics Inc. Files Final Prospectus for $270 Million Public Offering, Expanding Shareholder Opportunities

BUZZ-U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy

BRIEF-Dianthus Therapeutics Announces Pricing Of Upsized $251 Million Underwritten Public Offering

BUZZ-Dianthus Therapeutics surges again ahead of planned equity raise

Dianthus Therapeutics Is Maintained at Outperform by Baird

Dianthus Therapeutics Inc. Announces $150 Million Underwritten Public Offering to Advance Antibody Therapeutics Development

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DNTH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DNTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DNTH\",,,,,undefined,":{"symbol":"DNTH","market":"US","secType":"STK","nameCN":"Dianthus Therapeutics Inc.","latestPrice":32.92,"timestamp":1761336000000,"preClose":33.27,"halted":0,"volume":779367,"hourTrading":{"tag":"盘后","latestPrice":32.92,"preClose":32.92,"latestTime":"16:26 EDT","volume":5484,"amount":180534.58,"timestamp":1761337605764},"delay":0,"floatShares":21075200,"shares":39804400,"eps":-3.249007,"marketStatus":"Market Closed","change":-0.35,"latestTime":"10-24 16:00:00 EDT","open":33.69,"high":33.8,"low":32.35,"amount":25752303.758893,"amplitude":0.043583,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.249007,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1761552000000},"marketStatusCode":7,"adr":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":33.27,"preHourTrading":{"tag":"盘前","latestPrice":33.97,"preClose":33.27,"latestTime":"09:20 EDT","volume":244,"amount":8129.5798,"timestamp":1761312025030},"postHourTrading":{"tag":"盘后","latestPrice":32.92,"preClose":32.92,"latestTime":"16:26 EDT","volume":5484,"amount":180534.58,"timestamp":1761337605764},"volumeRatio":1.6251865787638577,"impliedVol":0.6712,"impliedVolPercentile":0.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DNTH\",,,,,undefined,":{"symbol":"DNTH","floatShares":21075200,"roa":"-23.37%","roe":"-34.71%","lyrEps":-2.55056,"volumeRatio":1.6251865787638577,"shares":39804400,"dividePrice":0,"high":33.8,"amplitude":0.043583,"preClose":33.27,"low":32.35,"week52Low":13.365,"pbRate":"4.32","psRate":"269.95","week52High":40.16,"institutionHeld":0,"latestPrice":32.92,"eps":-3.249007,"divideRate":0,"volume":779367,"delay":0,"ttmEps":-3.249007,"open":33.69,"prevYearClose":21.8,"prevWeekClose":35.65,"prevMonthClose":39.35,"prevQuarterClose":39.35,"fiveDayClose":35.65,"twentyDayClose":36.71,"sixtyDayClose":20.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DNTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-07","symbol":"DNTH","fiscalQuarterEnding":"2025/06","expectedEps":-0.86,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.88},{"market":"US","date":"2025-05-12","symbol":"DNTH","fiscalQuarterEnding":"2025/03","expectedEps":-0.86,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.82},{"market":"US","date":"2025-03-11","symbol":"DNTH","fiscalQuarterEnding":"2024/12","expectedEps":-0.85,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"post","actualEps":-0.81},{"market":"US","date":"2024-11-07","symbol":"DNTH","fiscalQuarterEnding":"2024/09","expectedEps":-0.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.74},{"market":"US","date":"2024-08-08","symbol":"DNTH","fiscalQuarterEnding":"2024/06","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.51}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DNTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DNTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":14,"updateTime":1760673600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DNTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DNTH","date":"2025-10-24","current":-10.132327,"percent":0.430279,"low":-21.520733,"twenty":-14.705712,"median":-10.234448,"eighty":-5.826546,"high":-2.378652,"avg":-10.314068,"sd":4.462361,"marketCap":1286757972},"quantilePoints":[{"date":"2023-09-22","current":-6.821887,"twenty":-6.869759,"median":-6.842701,"eighty":-6.807317,"marketCap":194260047},{"date":"2023-09-29","current":-5.576152,"twenty":-6.838538,"median":-5.576152,"eighty":-5.435929,"marketCap":201460812},{"date":"2023-10-06","current":-4.920135,"twenty":-6.800032,"median":-5.4757,"eighty":-5.354747,"marketCap":177759540},{"date":"2023-10-13","current":-4.916034,"twenty":-6.077097,"median":-5.403948,"eighty":-4.942276,"marketCap":177611407},{"date":"2023-10-20","current":-5.11694,"twenty":-5.587632,"median":-5.309646,"eighty":-5.016077,"marketCap":184869921},{"date":"2023-10-27","current":-4.75613,"twenty":-5.576152,"median":-5.262494,"eighty":-4.957036,"marketCap":171834222},{"date":"2023-11-03","current":-4.920135,"twenty":-5.49415,"median":-5.12514,"eighty":-4.920135,"marketCap":177759540},{"date":"2023-11-10","current":-4.678228,"twenty":-5.457249,"median":-5.084139,"eighty":-4.879133,"marketCap":169019695},{"date":"2023-11-17","current":-3.935775,"twenty":-5.444949,"median":-4.957036,"eighty":-4.76023,"marketCap":169663374},{"date":"2023-11-24","current":-4.021709,"twenty":-5.412148,"median":-4.920135,"eighty":-4.674948,"marketCap":173367815},{"date":"2023-12-01","current":-3.842966,"twenty":-5.377707,"median":-4.920135,"eighty":-3.993522,"marketCap":165662579},{"date":"2023-12-08","current":-3.640162,"twenty":-5.338346,"median":-4.907834,"eighty":-3.949524,"marketCap":156920099},{"date":"2023-12-15","current":-2.684576,"twenty":-5.297345,"median":-4.846332,"eighty":-3.884902,"marketCap":115726721},{"date":"2023-12-22","current":-3.007688,"twenty":-5.267824,"median":-4.788931,"eighty":-3.85534,"marketCap":129655417},{"date":"2023-12-29","current":-3.482043,"twenty":-5.235843,"median":-4.75818,"eighty":-3.842966,"marketCap":150103929},{"date":"2024-01-05","current":-4.482315,"twenty":-5.235843,"median":-4.715129,"eighty":-3.861528,"marketCap":193223616},{"date":"2024-01-12","current":-4.05952,"twenty":-5.169421,"median":-4.670027,"eighty":-3.873902,"marketCap":174997769},{"date":"2024-01-19","current":-3.952961,"twenty":-5.12186,"median":-4.521845,"eighty":-3.879402,"marketCap":170404263},{"date":"2024-01-26","current":-6.135656,"twenty":-5.267824,"median":-4.661827,"eighty":-3.893152,"marketCap":264495873},{"date":"2024-02-02","current":-14.091886,"twenty":-5.428549,"median":-4.735629,"eighty":-3.901401,"marketCap":607473021},{"date":"2024-02-09","current":-15.77856,"twenty":-5.593373,"median":-4.788931,"eighty":-3.913775,"marketCap":680182147},{"date":"2024-02-16","current":-16.247836,"twenty":-6.141843,"median":-4.875033,"eighty":-3.933712,"marketCap":700411702},{"date":"2024-02-23","current":-16.322648,"twenty":-6.585949,"median":-4.911934,"eighty":-3.935775,"marketCap":703636704},{"date":"2024-03-01","current":-16.832731,"twenty":-6.855189,"median":-4.920135,"eighty":-3.939212,"marketCap":725625351},{"date":"2024-03-08","current":-17.220393,"twenty":-14.108208,"median":-4.920135,"eighty":-3.952961,"marketCap":742336722},{"date":"2024-03-15","current":-18.274564,"twenty":-15.869694,"median":-5.055438,"eighty":-3.952961,"marketCap":787779926},{"date":"2024-03-22","current":-19.002283,"twenty":-16.27504,"median":-5.103895,"eighty":-3.958461,"marketCap":819150396},{"date":"2024-03-28","current":-20.617859,"twenty":-16.390659,"median":-5.12104,"eighty":-3.98046,"marketCap":898010856},{"date":"2024-04-05","current":-16.662734,"twenty":-16.662734,"median":-5.235843,"eighty":-3.987335,"marketCap":725745374},{"date":"2024-04-12","current":-16.777278,"twenty":-16.777278,"median":-5.350646,"eighty":-3.990772,"marketCap":730734324},{"date":"2024-04-19","current":-15.922581,"twenty":-16.832731,"median":-5.444949,"eighty":-3.99421,"marketCap":693508032},{"date":"2024-04-26","current":-14.143673,"twenty":-16.777278,"median":-5.535151,"eighty":-4.021709,"marketCap":616027659},{"date":"2024-05-03","current":-16.178636,"twenty":-16.662734,"median":-5.637242,"eighty":-4.021709,"marketCap":704660510},{"date":"2024-05-10","current":-14.570862,"twenty":-16.662734,"median":-6.140812,"eighty":-4.049207,"marketCap":731661246},{"date":"2024-05-17","current":-15.342363,"twenty":-16.621896,"median":-6.530951,"eighty":-4.05952,"marketCap":770401432},{"date":"2024-05-24","current":-12.724299,"twenty":-16.45867,"median":-6.737265,"eighty":-4.100768,"marketCap":638937940},{"date":"2024-05-31","current":-12.098897,"twenty":-16.404261,"median":-6.842701,"eighty":-4.106268,"marketCap":607534008},{"date":"2024-06-07","current":-12.233329,"twenty":-16.390659,"median":-12.098897,"eighty":-4.121392,"marketCap":614284386},{"date":"2024-06-14","current":-15.75779,"twenty":-16.354335,"median":-12.233329,"eighty":-4.176389,"marketCap":791261684},{"date":"2024-06-21","current":-15.114854,"twenty":-16.327131,"median":-12.630781,"eighty":-4.296009,"marketCap":758977268},{"date":"2024-06-28","current":-14.565435,"twenty":-16.324142,"median":-12.706764,"eighty":-4.381256,"marketCap":731388767},{"date":"2024-07-05","current":-15.459702,"twenty":-16.325636,"median":-12.794437,"eighty":-4.452753,"marketCap":776293455},{"date":"2024-07-12","current":-16.932611,"twenty":-16.417863,"median":-13.066224,"eighty":-4.47819,"marketCap":850254116},{"date":"2024-07-15","current":-16.920921,"twenty":-16.466954,"median":-13.180199,"eighty":-4.480252,"marketCap":849667127},{"date":"2024-08-02","current":-16.371502,"twenty":-16.45867,"median":-13.180199,"eighty":-4.482315,"marketCap":822078626},{"date":"2024-08-09","current":-13.845994,"twenty":-16.50009,"median":-13.738229,"eighty":-4.561374,"marketCap":784804801},{"date":"2024-08-16","current":-15.438194,"twenty":-16.45867,"median":-13.792112,"eighty":-4.661827,"marketCap":875052279},{"date":"2024-08-23","current":-14.304023,"twenty":-16.390659,"median":-14.112289,"eighty":-4.678228,"marketCap":810766318},{"date":"2024-08-30","current":-14.899592,"twenty":-16.390659,"median":-14.219338,"eighty":-4.715129,"marketCap":844523786},{"date":"2024-09-06","current":-14.490462,"twenty":-16.375333,"median":-14.311791,"eighty":-4.74793,"marketCap":821333873},{"date":"2024-09-13","current":-14.402421,"twenty":-16.338396,"median":-14.319559,"eighty":-4.75941,"marketCap":816343639},{"date":"2024-09-20","current":-14.552608,"twenty":-16.324142,"median":-14.311791,"eighty":-4.783191,"marketCap":824856392},{"date":"2024-09-27","current":-13.993291,"twenty":-16.306326,"median":-14.304023,"eighty":-4.815172,"marketCap":793153726},{"date":"2024-10-04","current":-14.221161,"twenty":-16.285922,"median":-14.291076,"eighty":-4.861093,"marketCap":806069627},{"date":"2024-10-11","current":-14.672555,"twenty":-16.269355,"median":-14.319559,"eighty":-4.877493,"marketCap":831655088},{"date":"2024-10-18","current":-14.522306,"twenty":-16.254626,"median":-14.311791,"eighty":-4.902094,"marketCap":823138846},{"date":"2024-10-25","current":-14.475677,"twenty":-16.248614,"median":-14.360865,"eighty":-4.914394,"marketCap":820495874},{"date":"2024-10-31","current":-14.486039,"twenty":-16.239675,"median":-14.366036,"eighty":-4.918495,"marketCap":821083201},{"date":"2024-11-08","current":-13.087312,"twenty":-16.213004,"median":-14.381745,"eighty":-4.920135,"marketCap":878053924},{"date":"2024-11-15","current":-11.244659,"twenty":-16.189942,"median":-14.360865,"eighty":-4.920135,"marketCap":754426637},{"date":"2024-11-22","current":-8.941908,"twenty":-16.180782,"median":-14.311791,"eighty":-4.920135,"marketCap":599930480},{"date":"2024-11-29","current":-10.582949,"twenty":-16.17095,"median":-14.273283,"eighty":-4.920135,"marketCap":710031190},{"date":"2024-12-06","current":-10.437372,"twenty":-16.142849,"median":-14.241876,"eighty":-4.934895,"marketCap":700264191},{"date":"2024-12-13","current":-10.36679,"twenty":-16.097823,"median":-14.188265,"eighty":-4.996397,"marketCap":695528677},{"date":"2024-12-20","current":-10.163866,"twenty":-16.05809,"median":-14.112289,"eighty":-5.061998,"marketCap":681914073},{"date":"2024-12-27","current":-10.14622,"twenty":-16.019613,"median":-14.091886,"eighty":-5.076759,"marketCap":680730195},{"date":"2025-01-03","current":-10.234448,"twenty":-15.922581,"median":-13.957579,"eighty":-5.096439,"marketCap":686649588},{"date":"2025-01-10","current":-11.284361,"twenty":-15.89482,"median":-13.822388,"eighty":-5.108369,"marketCap":757090364},{"date":"2025-01-17","current":-8.474299,"twenty":-15.887478,"median":-13.728741,"eighty":-5.115822,"marketCap":568557697},{"date":"2025-01-24","current":-9.828599,"twenty":-15.834329,"median":-13.708453,"eighty":-5.12186,"marketCap":659420380},{"date":"2025-01-31","current":-9.603618,"twenty":-15.788231,"median":-13.553088,"eighty":-5.191562,"marketCap":644325928},{"date":"2025-02-07","current":-10.128574,"twenty":-15.779567,"median":-13.462457,"eighty":-5.235843,"marketCap":679546316},{"date":"2025-02-14","current":-10.644708,"twenty":-15.766098,"median":-13.180199,"eighty":-5.267824,"marketCap":714174765},{"date":"2025-02-21","current":-10.455018,"twenty":-15.745542,"median":-13.087312,"eighty":-5.305545,"marketCap":701448070},{"date":"2025-02-28","current":-9.285997,"twenty":-15.702913,"median":-12.81575,"eighty":-5.346546,"marketCap":623016113},{"date":"2025-03-07","current":-10.375613,"twenty":-15.663831,"median":-12.724299,"eighty":-5.384267,"marketCap":696120616},{"date":"2025-03-14","current":-8.045567,"twenty":-15.60664,"median":-12.588406,"eighty":-5.420348,"marketCap":683623809},{"date":"2025-03-21","current":-7.727979,"twenty":-15.500032,"median":-12.233329,"eighty":-5.449869,"marketCap":656638658},{"date":"2025-03-28","current":-7.512473,"twenty":-15.459702,"median":-12.013661,"eighty":-5.472009,"marketCap":638327306},{"date":"2025-04-04","current":-6.416037,"twenty":-15.451099,"median":-11.624039,"eighty":-5.526951,"marketCap":545164287},{"date":"2025-04-11","current":-5.898066,"twenty":-15.431979,"median":-11.290978,"eighty":-5.587632,"marketCap":501152792},{"date":"2025-04-17","current":-7.175981,"twenty":-15.413286,"median":-11.262304,"eighty":-5.60754,"marketCap":609735897},{"date":"2025-04-25","current":-8.026663,"twenty":-15.369114,"median":-11.0285,"eighty":-5.622077,"marketCap":682017550},{"date":"2025-05-02","current":-8.204554,"twenty":-15.321347,"median":-10.898364,"eighty":-5.689407,"marketCap":697132746},{"date":"2025-05-09","current":-7.796217,"twenty":-15.230244,"median":-10.759405,"eighty":-5.898822,"marketCap":662436738},{"date":"2025-05-16","current":-5.986178,"twenty":-15.201008,"median":-10.704262,"eighty":-5.916298,"marketCap":602999662},{"date":"2025-05-23","current":-5.861665,"twenty":-15.193619,"median":-10.675588,"eighty":-5.916298,"marketCap":590457269},{"date":"2025-05-30","current":-5.698841,"twenty":-15.181369,"median":-10.600594,"eighty":-5.861665,"marketCap":574055678},{"date":"2025-06-06","current":-5.92871,"twenty":-15.126544,"median":-10.582949,"eighty":-5.698841,"marketCap":597210865},{"date":"2025-06-13","current":-6.15858,"twenty":-15.114854,"median":-10.503543,"eighty":-5.724382,"marketCap":620366052},{"date":"2025-06-20","current":-5.567944,"twenty":-15.086799,"median":-10.455018,"eighty":-5.687986,"marketCap":560870086},{"date":"2025-06-27","current":-5.788235,"twenty":-15.056571,"median":-10.424138,"eighty":-5.643102,"marketCap":583060473},{"date":"2025-07-03","current":-6.018104,"twenty":-15.025316,"median":-10.371201,"eighty":-5.641637,"marketCap":606215660},{"date":"2025-07-11","current":-6.580007,"twenty":-15.002134,"median":-10.30503,"eighty":-5.677131,"marketCap":662817229},{"date":"2025-07-18","current":-6.496998,"twenty":-14.98745,"median":-10.28959,"eighty":-5.714166,"marketCap":654455633},{"date":"2025-07-25","current":-6.956737,"twenty":-14.950568,"median":-10.234448,"eighty":-5.730129,"marketCap":700766007},{"date":"2025-08-01","current":-6.599162,"twenty":-14.912021,"median":-10.163866,"eighty":-5.73396,"marketCap":664746827},{"date":"2025-08-08","current":-6.113883,"twenty":-14.897039,"median":-10.14622,"eighty":-5.764609,"marketCap":615863655},{"date":"2025-08-15","current":-5.680098,"twenty":-14.891675,"median":-10.102106,"eighty":-5.714166,"marketCap":651813986},{"date":"2025-08-22","current":-6.633794,"twenty":-14.884329,"median":-10.031524,"eighty":-5.730129,"marketCap":761254359},{"date":"2025-08-29","current":-6.959172,"twenty":-14.857999,"median":-9.84404,"eighty":-5.73396,"marketCap":798592839},{"date":"2025-09-05","current":-6.917097,"twenty":-14.83641,"median":-9.826394,"eighty":-5.754393,"marketCap":793764587},{"date":"2025-09-12","current":-10.61968,"twenty":-14.806372,"median":-9.828599,"eighty":-5.786319,"marketCap":1218650741},{"date":"2025-09-19","current":-13.100588,"twenty":-14.770844,"median":-9.916203,"eighty":-5.789512,"marketCap":1503344826},{"date":"2025-09-26","current":-12.079369,"twenty":-14.762402,"median":-10.031524,"eighty":-5.797813,"marketCap":1386155868},{"date":"2025-10-03","current":-12.446738,"twenty":-14.758601,"median":-10.102106,"eighty":-5.811222,"marketCap":1428312952},{"date":"2025-10-10","current":-11.711999,"twenty":-14.750427,"median":-10.14622,"eighty":-5.817199,"marketCap":1343998784},{"date":"2025-10-17","current":-12.133294,"twenty":-14.726754,"median":-10.163866,"eighty":-5.821144,"marketCap":1392344064},{"date":"2025-10-24","current":-11.213186,"twenty":-14.705712,"median":-10.234448,"eighty":-5.826546,"marketCap":1286757972}],"updateTime":1761421325478},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DNTH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575710580","title":"Dianthus Therapeutics announces exclusive licensing agreement with Nanjing Leads Biolabs for DNTH212","url":"https://stock-news.laohu8.com/highlight/detail?id=2575710580","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575710580?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:00","pubTimestamp":1760612417,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc. announced it has entered into an exclusive licensing agreement with Nanjing Leads Biolabs Co., Ltd. for DNTH212, a bifunctional BDCA2 and BAFF/APRIL inhibitor. Under the terms of the agreement, Dianthus will pay Leads Biolabs up to $38 million, including $30 million in upfront and near-term milestone payments and an additional $8 million milestone upon initiation of a Dianthus-led Phase 1 study. Leads Biolabs is also eligible to receive up to $962 million in development, regulatory approval, and sales-based milestones, as well as tiered royalties on ex-Greater China net sales. Dianthus will hold exclusive rights to develop and commercialize DNTH212 globally outside of Greater China. The company estimates a pro forma cash balance of approximately $525 million following the transaction and reaffirms its cash runway into 2028.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide ac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL2cr6SH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B3QW5Z07.USD","BK4112","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2095319765.USD","LU0314104364.USD","NDAQ","BK4585","DNTH","LU2210149790.SGD","BK4139","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2575710658","title":"Dianthus Therapeutics Inc - Reaffirms Cash Runway Into 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2575710658","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575710658?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:00","pubTimestamp":1760612401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA4VLTFW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2575710635","title":"Dianthus Therapeutics Inc - Under the Term, Co to Pay Leads Biolabs up to $38 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2575710635","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575710635?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:00","pubTimestamp":1760612401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA4VLTFW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2575358710","title":"Dianthus Therapeutics Announces Exclusive License Agreement With Leads Biolabs for Dnth212, a First and Potentially Best-in-Class, Phase 1 Ready Bifunctional Bdca2 & Baff/April Inhibitor for Severe Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2575358710","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575358710?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:00","pubTimestamp":1760612401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA4VLTFW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2575106627","title":"Dianthus Therapeutics Inc - Estimated Pro Forma Cash Balance at $525 Mln Following the in-Licensing of Dnth212","url":"https://stock-news.laohu8.com/highlight/detail?id=2575106627","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575106627?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:00","pubTimestamp":1760612401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA4VLTFW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2575296556","title":"Dianthus initiated with a Buy at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2575296556","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575296556?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:10","pubTimestamp":1760436633,"startTime":"0","endTime":"0","summary":"Truist analyst Danielle Brill initiated coverage of Dianthus (DNTH) with a Buy rating and $56 price target The recent Phase 2 proof-of-concept resu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-initiated-with-a-buy-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-initiated-with-a-buy-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2572514951","title":"Dianthus Therapeutics Announces Positive Phase 2 Results for Claseprubart in Generalized Myasthenia Gravis; Data to Be Presented at 2025 AANEM Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2572514951","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572514951?lang=en_us&edition=fundamental","pubTime":"2025-10-02 20:00","pubTimestamp":1759406425,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Announces Positive Phase 2 Results for Claseprubart in Generalized Myasthenia Gravis; Data to Be Presented at 2025 AANEM Annual Meeting. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on October 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nNDL6Dl5K5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU0314104364.USD","BK4588","LU2210149790.SGD","NDAQ","DNTH","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","BK4139","IE00BKPKM429.USD","BK4112"],"gpt_icon":0},{"id":"2568295439","title":"Dianthus, Opendoor, and More Stocks See Action From Activist Investors -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2568295439","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568295439?lang=en_us&edition=fundamental","pubTime":"2025-09-20 03:26","pubTimestamp":1758309960,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Sept. 11 through Sept. 17, 2025. Source: VerityData. Opendoor Technologies  Access Industries reduced its stake in the real estate tech platform to 42,724,914 shares. Access Industries did so through the open market sale of 10,874,000 Opendoor Technologies shares on Sept. 12, 2025, at per share prices ranging from $8.77 to $9.77. On Sept. 10, director Pueo Keffer, who oversees venture capital at Access Industries, informed the board of his decision to retire from his position, effective immediately. Following the latest sales, Access continu","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ISBC","BK4211","OPEN","BK4216","BK4079","DNTH","VVX","BK4187","BK4562","BK4561","BK4144","DHT","LTH","BK4139"],"gpt_icon":1},{"id":"2568632664","title":"William Blair Keeps Their Buy Rating on Dianthus Therapeutics (DNTH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2568632664","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568632664?lang=en_us&edition=fundamental","pubTime":"2025-09-17 15:25","pubTimestamp":1758093912,"startTime":"0","endTime":"0","summary":"In a report released on September 13, Matt Phipps from William Blair reiterated a Buy rating on Dianthus Therapeutics. The company’s shares closed ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-keeps-their-buy-rating-on-dianthus-therapeutics-dnth-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-keeps-their-buy-rating-on-dianthus-therapeutics-dnth-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNTH"],"gpt_icon":0},{"id":"2568351084","title":"Dianthus initiated with a Buy at Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2568351084","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568351084?lang=en_us&edition=fundamental","pubTime":"2025-09-17 04:25","pubTimestamp":1758054318,"startTime":"0","endTime":"0","summary":"Clear Street analyst Bill Maughan initiated coverage of Dianthus (DNTH) with a Buy rating and $100 price target Dianthus is a biotech company prima...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-initiated-with-a-buy-at-clear-street-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-initiated-with-a-buy-at-clear-street-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2566697054","title":"Dianthus Therapeutics Is Maintained at Buy by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2566697054","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566697054?lang=en_us&edition=fundamental","pubTime":"2025-09-12 22:42","pubTimestamp":1757688120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DNTH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 12, 2025 10:42 ET (14:42 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SF","DNTH","LENZ"],"gpt_icon":0},{"id":"2566976637","title":"Dianthus price target raised to $44 from $42 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2566976637","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566976637?lang=en_us&edition=fundamental","pubTime":"2025-09-12 19:36","pubTimestamp":1757676968,"startTime":"0","endTime":"0","summary":"Wedbush raised the firm’s price target on Dianthus (DNTH) to $44 from $42 and keeps an Outperform rating on the shares. The firm is incorporating t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-price-target-raised-to-44-from-42-at-wedbush-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-price-target-raised-to-44-from-42-at-wedbush-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2566731569","title":"Wedbush Raises Price Target on Dianthus Therapeutics to $44 From $42, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2566731569","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566731569?lang=en_us&edition=fundamental","pubTime":"2025-09-12 18:41","pubTimestamp":1757673714,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics (DNTH) has an average rating of buy and mean price target of $60.60, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","DNTH"],"gpt_icon":0},{"id":"2566914932","title":"CFO Ryan Savitz Reports Disposal of Common Shares in Dianthus Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2566914932","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566914932?lang=en_us&edition=fundamental","pubTime":"2025-09-12 05:21","pubTimestamp":1757625684,"startTime":"0","endTime":"0","summary":"Ryan Savitz, CFO & CBO of Dianthus Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 11, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL7YcGdd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2566891960","title":"Dianthus Therapeutics Inc. Files Final Prospectus for $270 Million Public Offering, Expanding Shareholder Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2566891960","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566891960?lang=en_us&edition=fundamental","pubTime":"2025-09-11 19:21","pubTimestamp":1757589662,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc. has filed a final prospectus supplement with the U.S. Securities and Exchange Commission detailing the terms of its latest public offering. The company plans to issue and sell 6,487,879 shares of its common stock at a public offering price of $33.00 per share. Additionally, Dianthus will offer pre-funded warrants to purchase 1,112,121 shares of common stock at a price of $32.999 per warrant, which takes into account a $0.001 per share exercise price. The net proceeds from the offering, expected to be approximately $270 million, will be used after deducting underwriters' discounts, commissions, and estimated offering expenses. The offering is set to close on September 11, 2025, following the full exercise of an option by the underwriters to purchase an additional 1,140,000 shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL1SSBy4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2566983434","title":"BUZZ-U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2566983434","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566983434?lang=en_us&edition=fundamental","pubTime":"2025-09-11 00:05","pubTimestamp":1757520303,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen EnergyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nL6N3UX0RB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VST","CEG","ACHC","SNPS","BWA","FANG","PMVP","XOM","APA","HPQ","LEA","RNA","TRML","NEM","TLN","DHR","NVDU","PBPB","BW","ASST","GLSI","AMLX","JOBY","DRMA","FITB","TVTX","WALD","NKE","DNTH","LUCD","CHWY","HAL","RKT","GEV","ALNY","RAL","CVX","EQT","NVDD","AME"],"gpt_icon":1},{"id":"2566623009","title":"BRIEF-Dianthus Therapeutics Announces Pricing Of Upsized $251 Million Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2566623009","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566623009?lang=en_us&edition=fundamental","pubTime":"2025-09-10 10:37","pubTimestamp":1757471843,"startTime":"0","endTime":"0","summary":"BRIEF-Dianthus Therapeutics Announces Pricing Of Upsized $251 Million Underwritten Public OfferingSept 9 (Reuters) - Dianthus Therapeutics Inc DNTH.O:DIANTHUS THERAPEUTICS, INC. ANNOUNCES PRICING OF U","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nTUA4XDVSS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2566160614","title":"BUZZ-Dianthus Therapeutics surges again ahead of planned equity raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2566160614","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566160614?lang=en_us&edition=fundamental","pubTime":"2025-09-10 01:17","pubTimestamp":1757438252,"startTime":"0","endTime":"0","summary":"**  Dianthus Therapeutics' DNTH.O shares surge 13.2% on Tues to $36, highest since Apr 2022, adding to strong gain in previous session. ** DNTH shares on Mon finished up 20% after co's mid-stage trial win for its muscle-weakening drug claseprubart. ** After the bell Mon, co commenced $150 mln stock offering to fund preclinical and clinical development activities, and for working capital and general purposes. ** Jefferies, TD Cowen, Evercore and Stifel are joint bookrunners for the offering. ** Dianthus has ~32.19 mln shares outstanding for about $1.2 bln current market cap. ** Raymond James early Tues hiked its PT by $7 to $63. ** All 13 brokerages covering DNTH are bullish with \"strongbuy\" avg rating; median PT is $51.50, per LSEG data. ** With the move on the session, shares up ~90% over the past three months, putting them up ~65% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nL6N3UW0UY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1363072403.SGD","LU0971096721.USD","LU2265009873.SGD","IE00B3QW5Z07.USD","BK4139","BK4127","IE00BGHQF748.EUR","LU1804176565.USD","EVR","RJF","DNTH","IE00B64PRP62.GBP","BK4585","BK4588"],"gpt_icon":0},{"id":"2566949606","title":"Dianthus Therapeutics Is Maintained at Outperform by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2566949606","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566949606?lang=en_us&edition=fundamental","pubTime":"2025-09-09 19:50","pubTimestamp":1757418600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DNTH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 09, 2025 07:50 ET (11:50 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","DNTH"],"gpt_icon":0},{"id":"2566063415","title":"Dianthus Therapeutics Inc. Announces $150 Million Underwritten Public Offering to Advance Antibody Therapeutics Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2566063415","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566063415?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:00","pubTimestamp":1757361613,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc., a clinical-stage biotechnology company focused on developing antibody complement therapeutics for severe autoimmune diseases, has announced a proposed $150 million underwritten public offering. The offering consists of shares of its common stock, with an option for certain investors to choose pre-funded warrants instead. Additionally, the company may grant underwriters a 30-day option to purchase up to an additional $22.5 million of common stock. The offering is subject to market conditions, and Dianthus plans to use the net proceeds to support its preclinical and clinical development activities, as well as for general corporate purposes. Jefferies, TD Cowen, Evercore ISI, and Stifel are serving as joint book-running managers for the offering. The offering will be conducted under an effective shelf registration statement filed with the SEC.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT str","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDL1ybFfD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2095319765.USD","LU2210150020.SGD","BK4585","BK4112","DNTH","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU0314104364.USD","BK4127","EVR","BK4588","NDAQ","SF","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}]}}